News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
687,386 Results
Type
Article (39133)
Company Profile (282)
Press Release (647971)
Section
Business (203902)
Career Advice (1994)
Deals (35370)
Drug Delivery (89)
Drug Development (80838)
Employer Resources (168)
FDA (16097)
Job Trends (14810)
News (344662)
Policy (32480)
Tag
Academia (2530)
Alliances (49157)
Alzheimer's disease (1250)
Approvals (16033)
Artificial intelligence (143)
Bankruptcy (352)
Best Places to Work (11570)
Biotechnology (201)
Breast cancer (186)
Cancer (1323)
Cardiovascular disease (106)
Career advice (1662)
Cell therapy (269)
Clinical research (64588)
Collaboration (442)
Compensation (245)
COVID-19 (2540)
C-suite (106)
Data (1358)
Diabetes (163)
Diagnostics (6166)
Earnings (84873)
Employer resources (146)
Events (109930)
Executive appointments (364)
FDA (16726)
Funding (408)
Gene therapy (192)
GLP-1 (590)
Government (4331)
Healthcare (18686)
Infectious disease (2629)
Inflammatory bowel disease (110)
Interviews (309)
IPO (16328)
Job creations (3628)
Job search strategy (1418)
Layoffs (416)
Legal (7888)
Lung cancer (186)
Manufacturing (194)
Medical device (13210)
Medtech (13215)
Mergers & acquisitions (19173)
Metabolic disorders (431)
Neuroscience (1561)
NextGen Class of 2024 (6501)
Non-profit (4466)
Northern California (1638)
Obesity (250)
Opinion (180)
Patents (114)
People (56405)
Phase I (20085)
Phase II (28442)
Phase III (21209)
Pipeline (503)
Postmarket research (2560)
Preclinical (8541)
Radiopharmaceuticals (236)
Rare diseases (252)
Real estate (5891)
Regulatory (21624)
Research institute (2309)
Resumes & cover letters (349)
Southern California (1422)
Startups (3562)
United States (14733)
Vaccines (560)
Weight loss (175)
Date
Today (91)
Last 7 days (677)
Last 30 days (2729)
Last 365 days (35311)
2024 (34423)
2023 (40077)
2022 (51174)
2021 (55713)
2020 (54088)
2019 (46543)
2018 (35021)
2017 (32120)
2016 (31490)
2015 (37554)
2014 (31328)
2013 (26358)
2012 (28577)
2011 (29265)
2010 (27330)
Location
Africa (713)
Arizona (194)
Asia (37231)
Australia (6079)
California (3682)
Canada (1409)
China (290)
Colorado (167)
Connecticut (170)
Europe (79743)
Florida (513)
Georgia (130)
Illinois (372)
Indiana (218)
Kansas (96)
Maryland (614)
Massachusetts (2880)
Michigan (169)
Minnesota (285)
New Jersey (1062)
New York (1047)
North Carolina (732)
Northern California (1638)
Ohio (144)
Pennsylvania (901)
South America (1091)
Southern California (1422)
Texas (529)
Utah (105)
Washington State (391)
687,386 Results for "depuy inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
DePuy Synthes Receives 510(k) FDA Clearance of the VELYS™ Robotic-Assisted Solution for Use in Unicompartmental Knee Arthroplasty Procedures
Johnson & Johnson MedTech* announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson**, has received 510 FDA clearance for the clinical application of the VELYS™ Robotic-Assisted Solution in Unicompartmental Knee Arthroplasty.
June 7, 2024
·
9 min read
Press Releases
DePuy Synthes Launches its First Active Spine Robotics and Navigation Platform
August 2, 2024
·
6 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
FDA
DePuy Synthes Receives FDA Clearance for TELIGEN™ System
Today, Johnson & Johnson MedTech* announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its TELIGEN™ System.
October 20, 2022
·
10 min read
Press Releases
TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc.
December 12, 2024
·
19 min read
Biotech Beach
Innovative Platform for Tracking High-Value Medical DevicesTruepic to Work with “DePuy Synthes Canada*” to Increase Efficiency and Reduce Risk
Truepic, the leader in digital image provenance and authenticity, will work with DePuy Synthes Canada* by integrating the Truepic Vision platform seamlessly into their operations process.
August 1, 2022
·
1 min read
Press Releases
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
November 26, 2024
·
9 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
ImmunityBio, Inc. Announces Pricing of Public Offering of Common Stock
December 11, 2024
·
6 min read
Press Releases
Know Labs, Inc. Announces $300K Registered Direct Offering
December 13, 2024
·
4 min read
1 of 68,739
Next
